George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowi


Below are podcast interviews of individuals at UsAgainstAlzheimer’s that are recognized in the field and have been invited to share their expertise. Click Listen Now on the episodes of interest.